Israel Englander Celularity Inc Transaction History

Millennium Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.17 - $0.33 $76,359 - $148,228	-449,176 Reduced 58.42%	319,633 $79,000
Q2 2023 Aug 14, 2023	BUY	$0.42 - $0.81 $322,899 - $622,735	768,809 New	768,809 $407,000
Q4 2022 Feb 14, 2023	SELL	$1.08 - $2.35 $253,455 - $551,500	-234,681 Reduced 95.24%	11,717 $15,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $4.31 $78,014 - $781,958	181,429 Added 279.25%	246,398 $569,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.